Showing 38,601 - 38,620 results of 64,999 for search '(( 5 we decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.27s Refine Results
  1. 38601

    Intracellular LF82 multiplication requires stress responses. by Gaëlle Demarre (249248)

    Published 2019
    “…Horizontal lines indicate viability decrease by 2, 5 and 10 fold compared to WT LF82. Data were analyzed using a Student’s <i>t</i> test: * <i>P</i> <0.05, ** <i>P</i> <0.01, *** <i>P</i> <0.001, **** <i>P</i> <0.0001 (black stars correspond to mutant vs WT, blue stars correspond to mutant vs its complementation).…”
  2. 38602

    Homoleptic Ir(III) Phosphors with 2‑Phenyl-1,2,4-triazol-3-ylidene Chelates for Efficient Blue Organic Light-Emitting Diodes by Caifa You (10427035)

    Published 2021
    “…In this report, we synthesized two series of deep-blue-emitting homoleptic iridium­(III) phosphors bearing 1,2,4-triazol-3-ylidene and 5-(trifluoromethyl)-1,2,4-triazol-3-ylidene cyclometalate. …”
  3. 38603

    Homoleptic Ir(III) Phosphors with 2‑Phenyl-1,2,4-triazol-3-ylidene Chelates for Efficient Blue Organic Light-Emitting Diodes by Caifa You (10427035)

    Published 2021
    “…In this report, we synthesized two series of deep-blue-emitting homoleptic iridium­(III) phosphors bearing 1,2,4-triazol-3-ylidene and 5-(trifluoromethyl)-1,2,4-triazol-3-ylidene cyclometalate. …”
  4. 38604

    Homoleptic Ir(III) Phosphors with 2‑Phenyl-1,2,4-triazol-3-ylidene Chelates for Efficient Blue Organic Light-Emitting Diodes by Caifa You (10427035)

    Published 2021
    “…In this report, we synthesized two series of deep-blue-emitting homoleptic iridium­(III) phosphors bearing 1,2,4-triazol-3-ylidene and 5-(trifluoromethyl)-1,2,4-triazol-3-ylidene cyclometalate. …”
  5. 38605

    Homoleptic Ir(III) Phosphors with 2‑Phenyl-1,2,4-triazol-3-ylidene Chelates for Efficient Blue Organic Light-Emitting Diodes by Caifa You (10427035)

    Published 2021
    “…In this report, we synthesized two series of deep-blue-emitting homoleptic iridium­(III) phosphors bearing 1,2,4-triazol-3-ylidene and 5-(trifluoromethyl)-1,2,4-triazol-3-ylidene cyclometalate. …”
  6. 38606

    Data Sheet 1_Impact of primary production and net ecosystem metabolism on carbon and nutrient cycling at the land-sea interface.docx by Louise C. V. Rewrie (21016172)

    Published 2025
    “…When turbidity decreased in late spring (May), we observed elevated GPP rates, and highest GPP rates in summer (June-August), with seasonal averages of 613 ± 89 mg C m<sup>-2</sup> d<sup>-1</sup> in 2020 and 558 ± 77 mg C m<sup>-2</sup> d<sup>-1</sup> in 2021. …”
  7. 38607

    Homoleptic Ir(III) Phosphors with 2‑Phenyl-1,2,4-triazol-3-ylidene Chelates for Efficient Blue Organic Light-Emitting Diodes by Caifa You (10427035)

    Published 2021
    “…In this report, we synthesized two series of deep-blue-emitting homoleptic iridium­(III) phosphors bearing 1,2,4-triazol-3-ylidene and 5-(trifluoromethyl)-1,2,4-triazol-3-ylidene cyclometalate. …”
  8. 38608

    Network evolution in the presence of oscillating hub. by Samuel Goldman (1699888)

    Published 2023
    “…To decrease variance emerging from trial-to-trial variability, behavior is averaged over 30 trials for 1–3 targets, 20 trials for 4–5 targets, and 10 trials for 6–7 targets. …”
  9. 38609

    Image 4_Pronounced impairment of B cell differentiation during bone regeneration in adult immune experienced mice.tiff by Mireille Ngokingha Tchouto (20812811)

    Published 2025
    “…</p>Results<p>While the B cell proportion in young and non-immune experienced animals did not significantly change from 2 to 5 days post osteotomy in the hematoma, we found a significant decrease of the B cell proportion in the immune experienced mice, which was accompanied by the decreased expression of B cell specific genes, suggesting a specific response in immune experienced animals. …”
  10. 38610

    Table 1_Pronounced impairment of B cell differentiation during bone regeneration in adult immune experienced mice.xlsx by Mireille Ngokingha Tchouto (20812811)

    Published 2025
    “…</p>Results<p>While the B cell proportion in young and non-immune experienced animals did not significantly change from 2 to 5 days post osteotomy in the hematoma, we found a significant decrease of the B cell proportion in the immune experienced mice, which was accompanied by the decreased expression of B cell specific genes, suggesting a specific response in immune experienced animals. …”
  11. 38611

    Image 2_Pronounced impairment of B cell differentiation during bone regeneration in adult immune experienced mice.tiff by Mireille Ngokingha Tchouto (20812811)

    Published 2025
    “…</p>Results<p>While the B cell proportion in young and non-immune experienced animals did not significantly change from 2 to 5 days post osteotomy in the hematoma, we found a significant decrease of the B cell proportion in the immune experienced mice, which was accompanied by the decreased expression of B cell specific genes, suggesting a specific response in immune experienced animals. …”
  12. 38612

    Image 1_Pronounced impairment of B cell differentiation during bone regeneration in adult immune experienced mice.tiff by Mireille Ngokingha Tchouto (20812811)

    Published 2025
    “…</p>Results<p>While the B cell proportion in young and non-immune experienced animals did not significantly change from 2 to 5 days post osteotomy in the hematoma, we found a significant decrease of the B cell proportion in the immune experienced mice, which was accompanied by the decreased expression of B cell specific genes, suggesting a specific response in immune experienced animals. …”
  13. 38613

    Data Sheet 1_Pronounced impairment of B cell differentiation during bone regeneration in adult immune experienced mice.docx by Mireille Ngokingha Tchouto (20812811)

    Published 2025
    “…</p>Results<p>While the B cell proportion in young and non-immune experienced animals did not significantly change from 2 to 5 days post osteotomy in the hematoma, we found a significant decrease of the B cell proportion in the immune experienced mice, which was accompanied by the decreased expression of B cell specific genes, suggesting a specific response in immune experienced animals. …”
  14. 38614

    Image 3_Pronounced impairment of B cell differentiation during bone regeneration in adult immune experienced mice.tiff by Mireille Ngokingha Tchouto (20812811)

    Published 2025
    “…</p>Results<p>While the B cell proportion in young and non-immune experienced animals did not significantly change from 2 to 5 days post osteotomy in the hematoma, we found a significant decrease of the B cell proportion in the immune experienced mice, which was accompanied by the decreased expression of B cell specific genes, suggesting a specific response in immune experienced animals. …”
  15. 38615

    Table 2_Pronounced impairment of B cell differentiation during bone regeneration in adult immune experienced mice.xlsx by Mireille Ngokingha Tchouto (20812811)

    Published 2025
    “…</p>Results<p>While the B cell proportion in young and non-immune experienced animals did not significantly change from 2 to 5 days post osteotomy in the hematoma, we found a significant decrease of the B cell proportion in the immune experienced mice, which was accompanied by the decreased expression of B cell specific genes, suggesting a specific response in immune experienced animals. …”
  16. 38616

    Data_Sheet_1_Multimodal Optical Imaging to Investigate Spatiotemporal Changes in Cerebrovascular Function in AUDA Treatment of Acute Ischemic Stroke.docx by Han-Lin Wang (8638884)

    Published 2021
    “…Moreover, at post-stroke day 3, increased functional vascular density was observed in AUDA-treated rats (35.9 ± 1.9% higher than that in the control group, p < 0.05). At post-stroke day 7, a 105.4% ± 16.4% increase of astrocytes (p < 0.01), 30.0 ± 10.9% increase of neurons (p < 0.01), and 65.5 ± 15.0% decrease of microglia (p < 0.01) were observed in the penumbra region in AUDA-treated rats (N = 5 for each group). …”
  17. 38617

    Image_3_Visual-spatial processing impairment in the occipital-frontal connectivity network at early stages of Alzheimer’s disease.pdf by Iván Plaza-Rosales (14589380)

    Published 2023
    “…Participants (69–88 years old) with amnesic mild cognitive impairment–Clinical Dementia Rating scale (aMCI–CDR 0.5) were selected as probable early AD (eAD) by a neurologist specialized in dementia. …”
  18. 38618

    Image_2_Visual-spatial processing impairment in the occipital-frontal connectivity network at early stages of Alzheimer’s disease.pdf by Iván Plaza-Rosales (14589380)

    Published 2023
    “…Participants (69–88 years old) with amnesic mild cognitive impairment–Clinical Dementia Rating scale (aMCI–CDR 0.5) were selected as probable early AD (eAD) by a neurologist specialized in dementia. …”
  19. 38619

    Image_1_Different Renal Function Patterns in Patients With Acute Heart Failure: Relationship With Outcome and Congestion.jpeg by Alberto Palazzuoli (12203753)

    Published 2022
    “…</p>Results<p>We recruited 467 subjects with a mean congestion score of 3.5±1.08 and a median creatinine value of 1.28 (1.00–1.70) mg/dl, eGFR 50 (37–65) ml/min/m<sup>2</sup> and NTpro B-type natriuretic peptide (BNP) 7,000 (4,200–11,700) pg/ml. …”
  20. 38620

    Image_1_Visual-spatial processing impairment in the occipital-frontal connectivity network at early stages of Alzheimer’s disease.pdf by Iván Plaza-Rosales (14589380)

    Published 2023
    “…Participants (69–88 years old) with amnesic mild cognitive impairment–Clinical Dementia Rating scale (aMCI–CDR 0.5) were selected as probable early AD (eAD) by a neurologist specialized in dementia. …”